ClinicalTrials.Veeva

Menu

Local and Systemic Changes in Osteonecrosis of the Jawbone (SULVO)

M

Medical University of Graz

Status

Invitation-only

Conditions

Osteonecrosis of the Jaw

Study type

Observational

Funder types

Other

Identifiers

NCT05329558
30-196 ex 17/18

Details and patient eligibility

About

Osteonecrosis of the Jawbone (ONJ) is a serious complication of antiresorptive therapies (ARTs), for example with bisphosphonates or Denosumab. Especially long term treatment with intravenous antiresorptive agents causing lesions and, less frequent, also oral administration. This study aims at elucidating local and systemic changes in patients with ONJ.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • with/without ART
  • with/without MRONJ

Exclusion criteria

  • smoker (>10 cigarettes/day)
  • pregnancy

Trial design

100 participants in 4 patient groups

Healthy Controls
Patients with ART without MRONJ
Patients with oral ART with MRONJ
Patients with intravenous ART with MRONJ

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems